Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.
暂无分享，去创建一个
M. Schrappe | M. Eichelbaum | K. Welte | M. Schwab | A. Möricke | E. Schaeffeler | M. Stanulla | A. Schrauder | A. Reiter | P. Kaatsch | M. Zimmermann | S. Coulthard | G. Cario | H. Riehm | M. Dördelmann